Species Differences in Metabolism of Soluble Epoxide Hydrolase Inhibitor, EC1728, Highlight the Importance of Clinically Relevant Screening Mechanisms in Drug Development

by Cindy B. McReynolds, Jun Yang, Alonso Guedes, Christophe Morisseau, Roberto Garcia, Heather Knych, Caitlin Tearney, Briana Hamamoto, Sung Hee Hwang, Karen Wagner, Bruce D. Hammock
Published 2021-08-01

Selection of Potent Inhibitors of Soluble Epoxide Hydrolase for Usage in Veterinary Medicine

by Diyala S. Shihadih, Todd R. Harris, Sean D. Kodani, Sung-Hee Hwang, Kin Sing Stephen Lee, Kin Sing Stephen Lee, Vengai Mavangira, Briana Hamamoto, Alonso Guedes, Alonso Guedes, Bruce D. Hammock, Christophe Morisseau
Published 2020-08-01